SBTi Registry
Explore 1 matching companies with public, verified Science Based Targets commitments.
Data sourced from the Science Based Targets initiative (SBTi).
Show
20
per page| Sector | Region | Near-Term Status | Size | ||||
|---|---|---|---|---|---|---|---|
| Novartis AG | Pharmaceuticals, Biotechnology and Life Sciences | Europe | Targets set | Large | 2 | Jul 18, 2024 | |
Near-Term Status Targets set Near-Term Classification 1.5°C Near-Term Target Year 2030 Long-Term Status Targets set Net-Zero Status Targets set Net-Zero Year 2040 Sector Pharmaceuticals, Biotechnology and Life Sciences Region Europe Organization Type Corporate Location Switzerland Company Size Large Target Statement Overall Net-Zero Target: Novartis AG commits to reach net-zero greenhouse gas emissions across the value chain by 2040. Near-Term Targets: Novartis commits to reduce absolute scope 1 and 2 GHG emissions 90% by 2030 from a 2022 base year. Novartis also commits to reduce absolute… Stakeholders Global Head of Social Impact and Chief Sustainability Officer Net Zero Transition Lead | |||||||
Show
20
per pageTurn Commitments Into Impact
Thousands of companies have set public Scope 3 emissions-reduction targetsthrough SBTi, but few have the tools to deliver on them. Carbon3 gives you the infrastructure to plan, track, and execute the supply-chain decarbonization work behind your commitment, turning a public pledge into measurable progress. See how it works.